Effect of ramipril on the incidence of diabetes.

Effect of ramipril on the incidence of diabetes.

BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R
Materialtyp:	Journal article
Språk:	English
Publicerad:	2006

Liknande verk

Incidence of diabetes following ramipril or rosiglitazone withdrawal
av: Holman, R, et al.
Publicerad: (2011)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
av: Investigators, D
Publicerad: (2011)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
av: Punthakee, Z, et al.
Publicerad: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
av: Gerstein, H, et al.
Publicerad: (2006)

A Comparative Evaluation of Ramipril as Monotherapy and Combination of Ramipril with Torsemide in Hypertension
av: Navjot Kaur, et al.
Publicerad: (2017-11-01)

Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
av: G. Gulli
Publicerad: (2013-05-01)

Ramipril induced pemphigoid vulgaris
av: Mirza MA, et al.
Publicerad: (2018-09-01)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
av: Daniele Bosone, et al.
Publicerad: (2016-09-01)

Ramipril therapy in acute myocardial infarction
av: V. A. Lusov, et al.
Publicerad: (2008-10-01)

Ramipril poisoning rescued by naloxone and terlipressin
av: Samanta Samanta, et al.
Publicerad: (2014-01-01)

The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic
av: Katarzyna Regulska, et al.
Publicerad: (2023-02-01)

Effect of ramipril on renal function in patients with intermittent claudication
av: Simon D Hobbs, et al.
Publicerad: (2008-04-01)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
av: Hertzel C. Gerstein, et al.
Publicerad: (2022-08-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
av: I. V. Szirov, et al.
Publicerad: (2015-12-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
av: S. V. Nedogoda
Publicerad: (2016-09-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
av: Kateryna Typlynska, et al.
Publicerad: (2023-04-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
av: I. V. Szirov, et al.
Publicerad: (2015-12-01)

V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii
av: I E Chazova, et al.
Publicerad: (2011-09-01)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Publicerad: (2008)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
av: E. E. Averin, et al.
Publicerad: (2019-01-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
av: S. R. Willoughby, et al.
Publicerad: (2015-12-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
av: S. R. Willoughby, et al.
Publicerad: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
av: B J C Onwubere, et al.
Publicerad: (2007-01-01)

MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
av: Paul Valensi MD, et al.
Publicerad: (2024-06-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
av: O. A. Terenteva, et al.
Publicerad: (2021-12-01)

Effect of Valsartan on the Incidence of Diabetes REPLY
av: Holman, R, et al.
Publicerad: (2010)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
av: I. E. Chazova, et al.
Publicerad: (2010-08-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
av: V. I. Podzolkov, et al.
Publicerad: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
av: V. I. Podzolkov, et al.
Publicerad: (2015-09-01)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
av: McMurray, J, et al.
Publicerad: (2014)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
av: M. Dalla Vestra, et al.
Publicerad: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
av: A. I. Chesnikova, et al.
Publicerad: (2016-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
av: Katarzyna Regulska, et al.
Publicerad: (2021-10-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
av: M.A. Dolinnayä, et al.
Publicerad: (2017-03-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
av: A. G. Kuzmin, et al.
Publicerad: (2014-08-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
av: M. V. Leonova
Publicerad: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
av: D. A. Napalkov, et al.
Publicerad: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
av: A. A. Shadrin, et al.
Publicerad: (2019-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
av: Duygun Altıntaş Aykan, et al.
Publicerad: (2020-10-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
av: D. A. Napalkov, et al.
Publicerad: (2016-01-01)